{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:44:16Z","timestamp":1790520256440,"version":"4.1.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T00:00:00Z","timestamp":1431388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0125898","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T17:55:02Z","timestamp":1431453302000},"page":"e0125898","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":89,"title":["Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine"],"prefix":"10.1371","volume":"10","author":[{"given":"Yifan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9la","family":"Kecsk\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle","family":"Copmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berten","family":"Ceulemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Lagae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A. M.","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila V.","family":"Esguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,12]]},"reference":[{"issue":"Suppl 2","key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","article-title":"The core Dravet syndrome phenotype","volume":"52","author":"C Dravet","year":"2011","journal-title":"Epilepsia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/dmcn.12322","article-title":"Atypical multifocal Dravet syndrome lacks generalized seizures and may show later cognitive decline","volume":"56","author":"YO Kim","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","article-title":"De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy","volume":"68","author":"L Claes","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"Suppl 1","key":"ref4","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ejpn.2012.04.007","article-title":"Diagnosis and long-term course of Dravet syndrome","volume":"16","author":"IE Scheffer","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"issue":"Suppl 1","key":"ref5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejpn.2012.04.006","article-title":"Dravet syndrome: the main issues","volume":"16","author":"R Guerrini","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"issue":"Suppl 2","key":"ref6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2011.02997.x","article-title":"The genetics of Dravet syndrome","volume":"52","author":"C Marini","year":"2011","journal-title":"Epilepsia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40263-012-0035-9","article-title":"A revisited strategy for antiepileptic drug development in children: designing an initial exploratory step","volume":"27","author":"C Chiron","year":"2013","journal-title":"CNS Drugs"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group","volume":"356","author":"C Chiron","year":"2000","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.eplepsyres.2014.02.008","article-title":"Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence","volume":"108","author":"Y Inoue","year":"2014","journal-title":"Epilepsy Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1528-1157.1999.tb02048.x","article-title":"Stiripentol: efficacy and tolerability in children with epilepsy","volume":"40","author":"J Perez","year":"1999","journal-title":"Epilepsia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"M Bialer","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrneurol.2014.58","article-title":"The challenges and innovations for therapy in children with epilepsy","volume":"10","author":"JM Wilmshurst","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1528-1167.2012.03495.x","article-title":"Successful use of fenfluramine as an add-on treatment for Dravet syndrome","volume":"53","author":"B Ceulemans","year":"2012","journal-title":"Epilepsia"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1037\/a0014103","article-title":"Dual dopamine\/serotonin releasers: potential treatment agents for stimulant addiction","volume":"16","author":"RB Rothman","year":"2008","journal-title":"Exp Clin Psychopharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1517\/13543784.15.3.257","article-title":"The potential use of selective 5-HT2C agonists in treating obesity","volume":"15","author":"BM Smith","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/0192623310378027","article-title":"Drug-induced valvulopathy: an update","volume":"38","author":"CS Elangbam","year":"2010","journal-title":"Toxicol Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn1754","article-title":"Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy","volume":"9","author":"FH Yu","year":"2006","journal-title":"Nat Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1523\/JNEUROSCI.5270-06.2007","article-title":"Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation","volume":"27","author":"I Ogiwara","year":"2007","journal-title":"J Neurosci"},{"issue":"Suppl 2","key":"ref19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1528-1167.2011.03004.x","article-title":"Insights into pathophysiology and therapy from a mouse model of Dravet syndrome","volume":"52","author":"JC Oakley","year":"2011","journal-title":"Epilepsia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1073\/pnas.0813330106","article-title":"Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy","volume":"106","author":"JC Oakley","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/ncomms3410","article-title":"Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment","volume":"4","author":"SC Baraban","year":"2013","journal-title":"Nat Commun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s00239-005-0287-9","article-title":"Gene duplications and evolution of vertebrate voltage-gated sodium channels","volume":"63","author":"AE Novak","year":"2006","journal-title":"J Mol Evol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/dvdy.20811","article-title":"Embryonic and larval expression of zebrafish voltage-gated sodium channel alpha-subunit genes","volume":"235","author":"AE Novak","year":"2006","journal-title":"Dev Dyn"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1523\/JNEUROSCI.5193-09.2010","article-title":"Optogenetic localization and genetic perturbation of saccade-generating neurons in zebrafish","volume":"30","author":"PJ Schoonheim","year":"2010","journal-title":"J Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e54166","DOI":"10.1371\/journal.pone.0054166","article-title":"Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs","volume":"8","author":"T Afrikanova","year":"2013","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Baraban SC (2013) Forebrain electrophysiological recording in larval zebrafish. J Vis Exp.","DOI":"10.3791\/50104"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuroscience.2004.11.031","article-title":"Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression","volume":"131","author":"SC Baraban","year":"2005","journal-title":"Neuroscience"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/zeb.2009.0616","article-title":"From inflation to flotation: contribution of the swimbladder to whole-body density and swimming depth during development of the zebrafish (Danio rerio)","volume":"7","author":"BW Lindsey","year":"2010","journal-title":"Zebrafish"},{"key":"ref29","first-page":"103","article-title":"Severe myoclonic epilepsy in infancy: clinical analysis and relation to SCN1A mutations in a Japanese cohort","volume":"95","author":"H Oguni","year":"2005","journal-title":"Adv Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0387-7604(01)00276-5","article-title":"Severe myoclonic epilepsy in infants\u2014a review based on the Tokyo Women's Medical University series of 84 cases","volume":"23","author":"H Oguni","year":"2001","journal-title":"Brain Dev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5698\/1535-7511-14.s2.15","article-title":"Inflammatory processes, febrile seizures, and subsequent epileptogenesis","volume":"14","author":"M Choy","year":"2014","journal-title":"Epilepsy Curr"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s13311-014-0263-4","article-title":"Origins of temporal lobe epilepsy: febrile seizures and febrile status epilepticus","volume":"11","author":"KP Patterson","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"Suppl 2","key":"ref33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1469-8749.2011.03967.x","article-title":"Current therapeutic procedures in Dravet syndrome","volume":"53","author":"C Chiron","year":"2011","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl 2","key":"ref34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1528-1167.2011.03007.x","article-title":"The pharmacologic treatment of Dravet syndrome","volume":"52","author":"C Chiron","year":"2011","journal-title":"Epilepsia"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tins.2007.07.006","article-title":"Fever, febrile seizures and epilepsy","volume":"30","author":"CM Dube","year":"2007","journal-title":"Trends Neurosci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.expneurol.2012.06.013","article-title":"A novel zebrafish model of hyperthermia-induced seizures reveals a role for TRPV4 channels and NMDA-type glutamate receptors","volume":"237","author":"RF Hunt","year":"2012","journal-title":"Exp Neurol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.expneurol.2012.11.016","article-title":"Fishing for the mechanisms causing febrile seizures: employing a novel model to uncover the physiological generators of seizures with fever","volume":"240","author":"ED Marsh","year":"2013","journal-title":"Exp Neurol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1242\/dev.112003","article-title":"Out with the old, in with the new: reassessing morpholino knockdowns in light of genome editing technology","volume":"141","author":"S Schulte-Merker","year":"2014","journal-title":"Development"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0125898","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T17:58:01Z","timestamp":1589047081000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0125898"}},"subtitle":[],"editor":[{"given":"Yann","family":"Herault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,12]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0125898","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,12]]}}}